Ayva Pharma

A Leading International Pharmaceutical Company

A combination of regional authorities has come together to announce the establishment of a 4 mile square area devoted to manufacturing medical supplies, equipment and pharmaceuticals, to serve Egyptians and other countries. It will be situated in the Suez Canal Economic Zone (SCZone) and has been signed off by the General Authority for the SCZone, […]

Ayva Pharma were privileged to join over 4,400 of the world’s leading healthcare companies in exhibiting at the Annual Arab Health exhibition in Dubai at the end of January. Situated at the heart of the dedicated UK pavilion we welcomed many of our clients, both old and new, from all over the MENA region as […]

Following on from the World Health Organisation’s statement that 1 in 5 African children does not receive basic life-saving vaccines, they state that although African health organisations had improved greatly in overall access to immunisations across the continent over the previous 15 years, recently, ‘progress has stagnated’. Heads of State from across Africa gathered at […]

Foscavir, used to treat both cytomegalovirus (CMV) retinitis in patients with AIDS and aciclovir unresponsive Herpes Simplex Virus (HSV), is now exclusively distributed throughout much of the MENA region by Ayva Pharma. The anti-viral agent, Foscavir, adds to an impressive list of other drugs that Ayva has the exclusive rights to distribute throughout Saudi Arabia, […]

Following on from the first summit held last year in Geneva which focussed on ‘translating knowledge into action’, the project is once again aiming to help those, “in health research in Africa to learn about the full spectrum of ground-breaking scientific research currently underway, and prepare for the road ahead in Africa’s development as an […]

A rise in per capita income and subsequent change in lifestyle have been cited as the main causes for the significant increase in non-communicable, lifestyle related diseases across Saudi Arabia, including cardiovascular disease, circulatory disorders and diabetes, bringing a need for a raft of medicines to treat the conditions.  This has added to a number […]

Page 1 of 3